About InDevR
InDevR is a company based in Boulder (United States) founded in 2003 by Laura Kuck.. InDevR has raised $16 million across 15 funding rounds from investors including HHS, BioMerieux and National Dance Institute. InDevR offers products and services including VaxArray Platform, 5’CapQ Assay, and OmniFlu HA/NA 96. InDevR operates in a competitive market with competitors including Inflammatix, Agendia, Souzhou Ribo Life Science, GenomeDx Biosciences and Affymetrix, among others.
- Headquarter Boulder, United States
- Founders Laura Kuck
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Indevr, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16 M (USD)
in 15 rounds
-
Latest Funding Round
$9 M (USD), Series B
Jan 17, 2023
-
Investors
HHS
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of InDevR
InDevR offers a comprehensive portfolio of products and services, including VaxArray Platform, 5’CapQ Assay, and OmniFlu HA/NA 96. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Multiplexed platform for vaccine antigen testing and quantification
Assay for measuring mRNA integrity in vaccine formulations
Kit for rapid influenza antigen detection and analysis
Unlock access to complete
Funding Insights of InDevR
InDevR has successfully raised a total of $16M across 15 strategic funding rounds. The most recent funding activity was a Series B round of $9 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 15
- Last Round Series B — $9.0M
-
First Round
First Round
(01 Nov 2005)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Series B - InDevR | Valuation | Adjuvant Capital , BioMerieux |
|
| Aug, 2019 | Amount | Series A - InDevR | Valuation | Adjuvant Capital |
|
| Jul, 2014 | Amount | Grant - InDevR | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in InDevR
InDevR has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, BioMerieux and National Dance Institute. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is deployed for global health technology innovations.
|
Founded Year | Domain | Location | |
|
Developer of diagnostics devices for multiple health purposes
|
Founded Year | Domain | Location | |
|
Center of education providing teacher training courses
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by InDevR
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - InDevR
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Indevr Comparisons
Competitors of InDevR
InDevR operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Agendia, Souzhou Ribo Life Science, GenomeDx Biosciences and Affymetrix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Genomic diagnostic products for cancer treatment are provided.
|
|
| domain | founded_year | HQ Location |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| domain | founded_year | HQ Location |
Genomic tests for urologic cancers are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Provider of technologies for multiplex and simultaneous analysis of biological systems at the cell, protein, and gene level
|
|
| domain | founded_year | HQ Location |
Next-generation sequencing is provided for microbiology testing applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Indevr
Frequently Asked Questions about InDevR
When was InDevR founded?
InDevR was founded in 2003 and raised its 1st funding round 2 years after it was founded.
Where is InDevR located?
InDevR is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Is InDevR a funded company?
InDevR is a funded company, having raised a total of $16M across 15 funding rounds to date. The company's 1st funding round was a Grant of $2.9M, raised on Nov 01, 2005.
What does InDevR do?
Manufacturer of biotherapeutics, vaccines and diagnostic products. The company provides progressive analytical technologies that enhance and accelerate vaccine characterization and production. It also develops next-generation diagnostic products that will enable unprecedented tracking of seasonal and emerging influenza viruses around the globe. It offers a range of other microarray-related products. It provides the Cypher One product for automated hemagglutination analysis and the VaxArray Influenza potency assay for rapid quantification of hemagglutinin protein and many RD tools.
Who are the top competitors of InDevR?
InDevR's top competitors include Inflammatix, Agendia and Souzhou Ribo Life Science.
What products or services does InDevR offer?
InDevR offers VaxArray Platform, 5’CapQ Assay, and OmniFlu HA/NA 96.
Who are InDevR's investors?
InDevR has 4 investors. Key investors include HHS, BioMerieux, National Dance Institute, and Adjuvant Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.